Latest News about VIR
Recent news which mentions VIR
From Benzinga
The Top 7 Growth Stocks in Biotech
March 03, 2023
From InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
February 23, 2023
From Benzinga
From Benzinga
Earnings Scheduled For February 23, 2023
February 23, 2023
From Benzinga
Why CVRx Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
February 21, 2023
From Benzinga
Manitowoc, Helix Energy Solutions, JELD-WEN Holding And Other Big Stocks Moving Higher On Tuesday
February 21, 2023
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 21, 2023
February 21, 2023
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
February 21, 2023
From Benzinga
Overview Of Value Stocks In The Healthcare Sector
February 20, 2023
From Benzinga
Vir Biotech To Work On Next-Gen COVID-19 Solutions Independently, Or With Other Partners, As GSK Walks Out
February 14, 2023
From Benzinga
Outset Medical, SolarEdge Technologies And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
February 14, 2023
From Benzinga
Insiders Selling Meta Platforms And 3 Other Stocks
February 10, 2023
From Benzinga
The 7 Most Undervalued Biotech Stocks to Buy in February 2023
February 02, 2023
From InvestorPlace
7 Healthcare Stocks That Will Be Big Winners in 2023
January 31, 2023
From InvestorPlace
5 Value Stocks In The Healthcare Sector
January 30, 2023
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2023
January 27, 2023
From Benzinga
2 Stocks That Could Turn $100 Into $1,000 by 2028
January 22, 2023
From Motley Fool
Best stock picks for 2023: Here are Wall Street analysts’ most heavily favored choices
December 13, 2022
From MarketWatch
2 Fast-Growing Healthcare Stocks to Buy and Hold
December 02, 2022
From Motley Fool
BioNTech, Vertex Pharmaceuticals And Other Big Biotechnology Stocks From Benzinga's Most Accurate Analysts
December 02, 2022
From Benzinga
From Benzinga
After Bill Gates Dumps Billions In Berkshire To Buy Microsoft, His Quiet Biotech Portfolio Has Made A New Trade
November 18, 2022
From Benzinga
Don't Use These 5 Non-Cost Effective COVID Treatments Including Antivirals From Merck and Gilead, Britain's NICE Says
November 16, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
|
|
|